Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Eastridge Workforce Solutions acquires Operon Resource Management
Eastridge Workforce Solutions (San Diego, Calif.) recently announced that it has acquired Operon Resource Management (Lowell, Mass.). The financial details of the deal were not disclosed.
Operon’s medical device recruitment solutions will add on to Eastridge’s history of helping medtech manufacturers with their workforces. The clients from both companies will have access to specialized services that will make hiring and managing medtech workforces easier. Read more
4. India’s NPPA says it will not revisit stent price caps until Feb 2018
India’s National Pharmaceutical Pricing Authority said today it won’t be revising its cap on coronary stents, applied earlier this year, until Feb. 2018, according to a LiveMint report.
The regulatory body for India established price caps earlier this year that cut prices on coronary stents by over 80%, causing major players in the region to seek an exit from the market. Read more
3. Teva sells off the rest of its women’s health assets in $2.5B deal
After the company divested its Paragard intrauterine device assets for $1.1 billion in cash last week, Teva Pharmaceuticals announced today that it plans to sell off the rest of its global women’s health biz.
Combined with proceeds from its Paragard deal, the sale of Teva’s global women’s health assets will total $2.48 billion, the company reported. Teva said it plans to use the funds to repay term loan debt. Read more
2. Medtronic wins FDA nod for Intellis SCS, launches in US
Medtronic said today it won FDA approval for its Intellis implantable spinal cord stimulation system and launched it in the US.
The Fridley, Minn.-based company touted the newly revised system as the world’s smallest, and said that the new unit was designed to improve battery performance and standardize guidance and balancing of high-dose and low-dose therapy settings. Read more
1. Cambridge Medical Robotics raises $26m for Versius robot-assisted surgery device
Cambridge Medical Robotics, fresh from the unveiling of its Versius robot-assisted surgical arm, said today that it added $26 million to the Series A round it plans to use on validation studies and further production.
Existing backers Cambridge Innovation Capital, LGT Global Invest, Escala Capital and ABB Technology Ventures were joined by new investor Watrium in the round’s second tranche, taking the Series A total to $46 million, the Cambridge, U.K.-based company said. Read more
The post MassDevice.com +5 | The top 5 medtech stories for September 18, 2017 appeared first on MassDevice.
from MassDevice http://ift.tt/2xgAQoQ
Cap comentari:
Publica un comentari a l'entrada